Ebullition Pharmaceuticals Private Limited

Ebullition Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24230DL2016PTC290584 Incorporated 04 February 2016 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2022
₹4.23 Lakh
▼ 46% YoY
Net profit · FY 2022
₹682
Net margin 0.2%
EBITDA · FY 2022
₹2,397
EBITDA margin 0.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Ebullition Pharmaceuticals Private Limited

Data last updated:

Ebullition Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 04 February 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2016PTC290584. Its GSTIN is 10AAECE1993P1ZE (Bihar).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Pankaj Kumar (Managing Director) and Saurav Kumar.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at K – 19/1496 Sangam Vihar, New Delhi, Delhi, India – 110062.

As per the financials filed for FY 2022, the company reported a revenue of ₹4.23 Lakh, a decline of 46% compared to the previous year. For the same year it recorded a net profit of ₹682 (net margin 0.2%) and EBITDA of ₹2,397 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 38% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Ebullition Pharmaceuticals Private Limited
CIN U24230DL2016PTC290584
Registration Number 290584
Incorporation Date 04 February 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    K – 19/1496 Sangam Vihar, New Delhi, Delhi, India – 110062
  • Industry
    Trading, Other Wholesale, Wholesale
Comprehensive company report
Ebullition Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Ebullition Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ebullition Pharmaceuticals Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Ebullition Pharmaceuticals Private Limited

The main business activity of Ebullition Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Ebullition Pharmaceuticals Private Limited FY 2022 filings available

Ebullition Pharmaceuticals Private Limited reported revenue of ₹4.23 Lakh (down 46% YoY) for FY 2022.

Revenue · FY 2022
₹4.23 Lakh ▼ 46%
Net profit · FY 2022
₹682 margin 0.2%
EBITDA · FY 2022
₹2,397 margin 0.6%

Compounded Annual Growth Rate (CAGR) of Ebullition Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 15%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▼ 78%
3 years · compounded
▲ 26%
5 years · compounded
▲ 15%

Revenue fell 46% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA fell 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Ebullition Pharmaceuticals Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹2,397••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹682••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Ebullition Pharmaceuticals Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin0.6%••••••••••••••••
Net Profit Margin0.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ebullition Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Ebullition Pharmaceuticals Private Limited

Ebullition Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Prophends Pharmaceuticals (OPC) Private Limited₹4.26 Lakh (FY 2025)••••••••55.0%••••Patna, Bihar, India
Glorywarrior Pharmaceuticals (OPC) Private Limited₹4.26 Lakh (FY 2022)••••••••••••Ratnagiri, Maharashtra, India
Aptaas Pharmaceuticals Private Limited₹4.25 Lakh (FY 2018)••••••••-6.0%••••New Delhi, Delhi, India
Heivero Pharmaceuticals Limited₹4.25 Lakh (FY 2018)••••••••••••Uttar Pradesh, India
Sunchoice Pharmaceuticals Private Limited₹4.24 Lakh (FY 2024)••••••••-5.0%••••Moradabad, Uttar Pradesh, India
Ebullition Pharmaceuticals Private Limited this company₹4.23 Lakh (FY 2022)••••••••-46.0%••••New Delhi, Delhi, India
Smark Pharmaceuticals Private Limited₹4.23 Lakh (FY 2025)••••••••-2.0%••••Uttar Pradesh, India
Rabindra Pharmaceuticals Private Limited₹4.22 Lakh (FY 2025)••••••••-60.0%••••Muzaffarpur, Bihar, India
Avot Pharmaceuticals Private Limited₹4.21 Lakh (FY 2021)••••••••-73.0%••••Baddi, Himachal Pradesh, India
Mellowsky Pharmaceuticals Private Limited₹4.19 Lakh (FY 2024)••••••••••••Delhi, India
Bruce Pharmaceuticals Private Limited₹4.18 Lakh (FY 2016)••••••••6.0%••••Ahmedabad, Gujarat, India

Peers are the five companies nearest above and the five nearest below Ebullition Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Ebullition Pharmaceuticals Private Limited

Ebullition Pharmaceuticals Private Limited is audited by MUKTINATHSINHA for the financial year 2017.

NameStatusAppointment DateCessation Date
MUKTINATHSINHALockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Ebullition Pharmaceuticals Private Limited

Ebullition Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Saurav KumarDirector04 Feb 201610 Years 8 MonthsCurrent
Pankaj KumarManaging Director04 Feb 201610 Years 8 MonthsCurrent

Ownership and Shareholding of Ebullition Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Ebullition Pharmaceuticals Private Limited

Ebullition Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Ebullition Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Ebullition Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Ebullition Pharmaceuticals Private Limited

Ebullition Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Pankaj Kumar was appointed as Managing Director on 04 Feb 2016.

AGM
Ebullition Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Ebullition Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.
Appointed
Pankaj Kumar was appointed as Managing Director.
Appointed
Saurav Kumar was appointed as Director.
Incorporation
04 Feb 2016
Ebullition Pharmaceuticals Private Limited was registered on 04 Feb 2016 with Roc Delhi & aged 10 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Ebullition Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ebullition Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ebullition Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Ebullition Pharmaceuticals Private Limited

Ebullition Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AAECE1993P1ZEBiharActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ebullition Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ebullition Pharmaceuticals Private Limited

Ebullition Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 04 February 2016 (10+ years old) and is registered under CIN U24230DL2016PTC290584.

Ebullition Pharmaceuticals reported revenue of ₹4.23 Lakh for FY 2022 (down 46% YoY).

Ebullition Pharmaceuticals has 2 current directors:

Ebullition Pharmaceuticals reported a net profit of ₹682 (net margin 0.2%) and EBITDA of ₹2,397 (EBITDA margin 0.6%) for FY 2022, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Ebullition Pharmaceuticals is -15% over three years and 38% over five years. In the latest year (FY 2022) revenue fell 46%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Ebullition Pharmaceuticals is 10AAECE1993P1ZE, registered in Bihar.

The CIN (Corporate Identification Number) of Ebullition Pharmaceuticals is U24230DL2016PTC290584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ebullition Pharmaceuticals was incorporated on 04 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Ebullition Pharmaceuticals by revenue are Prophends Pharmaceuticals (OPC) Private Limited, Glorywarrior Pharmaceuticals (OPC) Private Limited, Aptaas Pharmaceuticals Private Limited, Heivero Pharmaceuticals Limited, Sunchoice Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Pankaj Kumar was appointed as Managing Director on 04 Feb 2016. Saurav Kumar was appointed as Director on 04 Feb 2016.

The registered office of Ebullition Pharmaceuticals is at K – 191496 Sangam Vihar, New Delhi, Delhi, India – 110062.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available